The quarterly results for Corpay, Inc. (NYSE:CPAY) were released last week, making it a good time to revisit its performance. It was a credible result overall, with revenues of US$1.0b and statutory earnings per share of US$3.40 both in line with analyst estimates, showing that Corpay is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
We've discovered 1 warning sign about Corpay. View them for free.
After the latest results, the 18 analysts covering Corpay are now predicting revenues of US$4.42b in 2025. If met, this would reflect a notable 9.2% improvement in revenue compared to the last 12 months. Per-share earnings are expected to grow 15% to US$16.55. In the lead-up to this report, the analysts had been modelling revenues of US$4.40b and earnings per share (EPS) of US$16.78 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
Check out our latest analysis for Corpay
The analysts reconfirmed their price target of US$394, showing that the business is executing well and in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Corpay analyst has a price target of US$445 per share, while the most pessimistic values it at US$330. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Corpay is an easy business to forecast or the the analysts are all using similar assumptions.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 12% growth on an annualised basis. That is in line with its 11% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 5.3% per year. So it's pretty clear that Corpay is forecast to grow substantially faster than its industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at US$394, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Corpay going out to 2027, and you can see them free on our platform here..
Plus, you should also learn about the 1 warning sign we've spotted with Corpay .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.